Tonix Pharmaceuticals Holding (STU:TPM0) EBIT per Share : €-157.39 (TTM As of Mar. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Tonix Pharmaceuticals Holding EBIT per Share?

Tonix Pharmaceuticals Holding's EBIT per Share for the three months ended in Mar. 2024 was €-7.77. Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2024 was €-157.39.

During the past 3 years, the average EBIT per Share Growth Rate was 59.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Tonix Pharmaceuticals Holding's EBIT per Share or its related term are showing as below:

STU:TPM0' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: 59.6 Med: 65.95 Max: 72.3
Current: 59.6

During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Tonix Pharmaceuticals Holding was 72.30% per year. The lowest was 59.60% per year. And the median was 65.95% per year.

STU:TPM0's 3-Year EBIT Growth Rate is ranked better than
95.79% of 1305 companies
in the Biotechnology industry
Industry Median: 3.4 vs STU:TPM0: 59.60

Tonix Pharmaceuticals Holding's EBIT for the three months ended in Mar. 2024 was €-19.64 Mil.

Tonix Pharmaceuticals Holding EBIT per Share Historical Data

The historical data trend for Tonix Pharmaceuticals Holding's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tonix Pharmaceuticals Holding EBIT per Share Chart

Tonix Pharmaceuticals Holding Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EBIT per Share

Get a 7-Day Free Trial

-25,945.00

-2,768.00

-1,433.26

-578.22

-204.05

Tonix Pharmaceuticals Holding Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EBIT per Share	Get a 7-Day Free Trial															-98.64	-80.87	-55.06	-13.68	-7.77

Tonix Pharmaceuticals Holding EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Tonix Pharmaceuticals Holding's EBIT per Share for the fiscal year that ended in Dec. 2023 is calculated as

	EBIT per Share		(A: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-108.554	/	0.532
=	-204.05

Tonix Pharmaceuticals Holding's EBIT per Share for the quarter that ended in Mar. 2024 is calculated as

	EBIT per Share		(Q: Mar. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-19.643	/	2.527
=	-7.77

EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-157.39

Tonix Pharmaceuticals Holding (STU:TPM0) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Tonix Pharmaceuticals Holding EBIT per Share Related Terms

Thank you for viewing the detailed overview of Tonix Pharmaceuticals Holding's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Tonix Pharmaceuticals Holding (STU:TPM0) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tonix Pharmaceuticals Holding Corp (STU:TPM0) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

TNXP:USA

Address

26 Main Street, Suite 101, Chatham, NJ, USA, 07928

Website

https://www.tonixpharma.com

Tonix Pharmaceuticals Holding Corp is a clinical-stage biopharmaceutical company focused on developing therapeutics and vaccines to treat and prevent human disease and alleviate suffering. its portfolio consists of the central nervous system, rare disease, immunology, and infectious disease product candidates. The CNS portfolio includes small molecules and biologics to treat pain, neurologic, psychiatric, and addiction conditions. CNS product candidate is TNX-102 SL, a proprietary sublingual tablet formulation of cyclobenzaprine (CBP) designed for bedtime administration.

Tonix Pharmaceuticals Holding (STU:TPM0) Headlines

No Headlines